Our findings showed that the noncytotoxic concentrations of HE pretreatment substantially inhibited the endothelial cell migration, invasion, and tube formation after challenge with TNF-α, which implies the potent antiangiogenic property of HE. The gene discussed is TNF; the disease is hereditary elliptocytosis.